Director/PDMR Shareholding

Hikma Pharmaceuticals Plc
05 December 2005


Hikma Pharmaceuticals PLC
5 December 2005

NOTIFICATION OF TRANSACTION OF DIRECTOR/PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY AND CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer 
should complete boxes 1 to 16, 23
and 24.

(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 
1 to 4, 6, 8,13, 14, 16, 23 and 24.

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial 
responsibilities should complete boxes 1 to 3 and 17 to 24.

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other 
than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.


Please complete all relevant boxes should in block capital letters.


1. Name of the issuer

HIKMA PHARMACEUTICALS PLC

....................................

2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or

(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii)

(iii)

....................................

3. Name of person discharging managerial responsibilities/director

MR BREFFNI BYRNE(DIRECTOR)

....................................

4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

....................................

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect 
of a non-beneficial interest

3 ABOVE

....................................

6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares

ORDINARY SHARES OF 10 PENCE EACH

....................................

7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them

MR BREFFNI BYRNE

....................................

8 State the nature of the transaction

ACQUISITION OF SHARES

....................................

9. Number of shares, debentures or financial instruments relating to shares
acquired

10,000

....................................

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when 
calculating percentage)

0.006%

....................................

11. Number of shares, debentures or financial instruments relating to shares disposed

N/A

....................................

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when 
calculating percentage)

N/A

....................................

13. Price per share or value of transaction

315 PENCE PER SHARE

....................................

14. Date and place of transaction

5 DECEMBER 2005, LONDON

....................................

15. Total holding following notification and total percentage holding following notification (any treasury shares 
should not be taken into account when calculating percentage)

10,000 ORDINARY SHARES (0.006%)

....................................

16. Date issuer informed of transaction

5 DECEMBER 2005

....................................

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes


17 Date of grant

....................................

18. Period during which or date on which it can be exercised

....................................

19. Total amount paid (if any) for grant of the option

....................................

20. Description of shares or debentures involved (class and number)

....................................

21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise

....................................

22. Total number of shares or debentures over which options held following
notification

....................................

23. Any additional information

N/A

....................................

24. Name of contact and telephone number for queries

HENRY KNOWLES, COMPANY SECRETARY, 0207 479 4870

....................................

Name and signature of duly authorised officer of issuer responsible for making notification

HENRY KNOWLES, COMPANY SECRETARY, 0207 479 4870

....................................

Date of notification

5 DECEMBER 2005

....................................

END




                      This information is provided by RNS
            The company news service from the London Stock Exchange